MA50414A - Composition à usage topique pour la cicatrisation améliorée des plaies ouvertes - Google Patents

Composition à usage topique pour la cicatrisation améliorée des plaies ouvertes

Info

Publication number
MA50414A
MA50414A MA050414A MA50414A MA50414A MA 50414 A MA50414 A MA 50414A MA 050414 A MA050414 A MA 050414A MA 50414 A MA50414 A MA 50414A MA 50414 A MA50414 A MA 50414A
Authority
MA
Morocco
Prior art keywords
composition
topical use
open wounds
improved healing
healing
Prior art date
Application number
MA050414A
Other languages
English (en)
Inventor
Mona E Buice
Joshua Z Greeson
David M Sailors
James Louis Wood
Jonathan Woody
Original Assignee
Mona E Buice
Joshua Z Greeson
David M Sailors
James Louis Wood
Jonathan Woody
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mona E Buice, Joshua Z Greeson, David M Sailors, James Louis Wood, Jonathan Woody filed Critical Mona E Buice
Publication of MA50414A publication Critical patent/MA50414A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA050414A 2017-10-19 2018-10-19 Composition à usage topique pour la cicatrisation améliorée des plaies ouvertes MA50414A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762574481P 2017-10-19 2017-10-19
US201862678574P 2018-05-31 2018-05-31

Publications (1)

Publication Number Publication Date
MA50414A true MA50414A (fr) 2020-08-26

Family

ID=66174274

Family Applications (1)

Application Number Title Priority Date Filing Date
MA050414A MA50414A (fr) 2017-10-19 2018-10-19 Composition à usage topique pour la cicatrisation améliorée des plaies ouvertes

Country Status (8)

Country Link
US (4) US20190290736A1 (fr)
EP (1) EP3697433A4 (fr)
AU (2) AU2018351352A1 (fr)
CA (1) CA3079544A1 (fr)
IL (2) IL274002B1 (fr)
MA (1) MA50414A (fr)
MX (2) MX2020004251A (fr)
WO (1) WO2019079710A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA50414A (fr) 2017-10-19 2020-08-26 Mona E Buice Composition à usage topique pour la cicatrisation améliorée des plaies ouvertes
US11707433B2 (en) * 2019-09-01 2023-07-25 Pathway Development Llc Methods and compositions for treating diabetic foot ulcers
WO2025010400A2 (fr) * 2023-07-05 2025-01-09 Eleos Pharmaceuticals, Inc. Compositions et procédés aux fins d'un traitement amélioré de plaies cutanées

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6155992A (en) * 1997-12-02 2000-12-05 Abbott Laboratories Method and apparatus for obtaining interstitial fluid for diagnostic tests
US20040037828A1 (en) 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
RU2203500C2 (ru) 2000-10-20 2003-04-27 Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" Способ диагностики ранних стадий диабетической ретинопатии
US20060009373A1 (en) 2004-07-08 2006-01-12 Max Martin Method for treating diabetic wounds
EP2046284A1 (fr) 2006-08-04 2009-04-15 Nastech Pharmaceutical Company Inc. Compositions pour administration intranasale d'insuline humaine et leurs utilisations
HUE050287T2 (hu) * 2009-02-13 2020-11-30 Boehringer Ingelheim Int SGLT2-inhibitort, DPP-IV-inhibitort és adott esetben egy további antidiabetikus hatóanyagot tartalmazó gyógyászati készítmény és alkalmazásai
WO2010097800A1 (fr) 2009-02-26 2010-09-02 Muhammad Abdulrazik Combinaison synergique de composés bioactifs pour diminuer la pression intraoculaire
US20110294730A1 (en) 2010-05-31 2011-12-01 Shantha Totada R Method of treating glaucoma and intraocular hypertension
US20120003296A1 (en) 2010-07-01 2012-01-05 Shantha Totada R New methods of treating dry eye syndrome
EP2637684A4 (fr) 2010-11-08 2014-05-07 Healor Ltd Compositions ophtalmiques tamponnées et leurs procédés d'utilisation
RU2013147883A (ru) 2011-04-01 2015-05-10 Юниверсити Оф Флорида Рисеч Фаундэйшн, Инк. Термочувствительные, мукоадгезивные или кожно-адгезивные и усиливающие проникновение композиции для местной доставки терапевтических средств
WO2013141730A1 (fr) * 2012-03-19 2013-09-26 Tecnifar-Indústria Técnica Farmacêutica, S.A. Compositions comprenant des cocktails de phages antibactériens et leurs utilisations pour le traitement d'infections bactériennes
CN103566359A (zh) 2012-07-18 2014-02-12 张雅琴 自拟冲洗液加冲吸式换药法治疗糖尿病足的应用
BR112015023650A2 (pt) 2013-03-15 2017-07-18 Prometheon Pharma Llc dispositivos, sistemas, e métodos para distribuição percutânea de componentes
AR099569A1 (es) * 2014-02-28 2016-08-03 Novo Nordisk As Derivados de insulina y los usos médicos de estos
EP3113764B1 (fr) 2014-03-04 2020-07-22 Eastgate Pharmaceuticals Inc. Composition pharmaceutique destinée à une administration transmucosale et méthodes de traitement du diabète chez un sujet en ayant besoin
US11623008B2 (en) * 2014-08-20 2023-04-11 Professional Compounding Centers Of America Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
US20160220581A1 (en) 2015-01-30 2016-08-04 Jds Therapeutics, Llc Chromium compositions for the treatment or prevention of diabetic retinopathy
MA50414A (fr) 2017-10-19 2020-08-26 Mona E Buice Composition à usage topique pour la cicatrisation améliorée des plaies ouvertes

Also Published As

Publication number Publication date
EP3697433A4 (fr) 2021-07-21
WO2019079710A1 (fr) 2019-04-25
IL323598A (en) 2025-11-01
MX2025011487A (es) 2025-11-03
US20230330190A1 (en) 2023-10-19
US20210162015A1 (en) 2021-06-03
CA3079544A1 (fr) 2019-04-25
US20250025534A1 (en) 2025-01-23
AU2024202400A1 (en) 2024-05-02
EP3697433A1 (fr) 2020-08-26
US11369664B2 (en) 2022-06-28
MX2020004251A (es) 2021-05-27
IL274002A (en) 2020-05-31
IL274002B1 (en) 2025-11-01
US12383607B2 (en) 2025-08-12
US20190290736A1 (en) 2019-09-26
AU2018351352A1 (en) 2020-05-28

Similar Documents

Publication Publication Date Title
EP3328414A4 (fr) Composition destinée à être utilisée pour favoriser la cicatrisation de plaies
HUE053115T2 (hu) Topikális gyógyszerészeti formulációk gyulladással összefüggõ állapotok kezelésére
DK3612215T3 (da) Sammensætninger til behandling af lungeinflammation
EP3436012A4 (fr) Pansements modifiés pour plaies
EP3573599A4 (fr) Compositions thérapeutiques topiques d'aprémilast
EP3380200A4 (fr) Compositions pour le traitement des cheveux
PL3484457T3 (pl) Kompozycja do stosowania miejscowego wspomagająca gojenie się ran
EP3193862C0 (fr) Composition topique de cannabinoïdes pour le traitement de la douleur arthritique
EP3735225A4 (fr) Compositions topiques soulageant la douleur
EP3380063A4 (fr) Compositions pour le traitement des cheveux
EP3746043A4 (fr) Compositions topiques
EP2968399A4 (fr) Compositions et méthodes d'utilisation de ces dernières pour la cicatrisation des plaies
EP3389624A4 (fr) Compositions cosmétiques topiques
EP3829538C0 (fr) Composition topique
PL3424499T3 (pl) Kompozycja farmaceutyczna do leczenia bólu neuropatycznego
MA50414A (fr) Composition à usage topique pour la cicatrisation améliorée des plaies ouvertes
EP3870125A4 (fr) Pansements fonctionnels pour la cicatrisation de plaies
EP3761952C0 (fr) Compositions topiques de soins de la peau
KR101894521B9 (ko) 흉터치료를 위한 국소용 약학적 조성물
DK2953621T3 (da) Topisk antimykotisk sammensætning til behandling af onykomykose
EP3804734A4 (fr) Composition topique
EP3576716C0 (fr) Composition topique
EP3354284A4 (fr) Composition pour le traitement de la douleur
DK3349752T3 (da) Aza-adamantan sammensætning til sårheling
MA50066A (fr) Compositions à usage topique pour le traitement de la leishmaniose cutanée